公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2015 | KRAS and KIT gatekeeper mutations confer polyclonal primary imatinib resistance in GI stromal tumors: Relevance of concomitant phosphatidylinositol 3-kinase/AKT dysregulation | Serrano C.; Wang Y.; Mariño-Enríquez A.; JEN-CHIEH LEE ; Ravegnini G.; Morgan J.A.; Bertagnolli M.M.; Beadling C.; Demetri G.D.; Corless C.L.; Heinrich M.C.; Fletcher J.A. | Journal of Clinical Oncology | 45 | 42 | |
2021 | Loss of SFRP1 expression is a key progression event in gastrointestinal stromal tumor pathogenesis | Liang C.-W.; CHING-YAO YANG ; Flavin R.; Fletcher J.A.; TZU-PIN LU ; I-RUE LAI ; Li Y.-I.; YIH-LEONG CHANG ; JEN-CHIEH LEE | Human Pathology | 6 | 5 |